Matches in Wikidata for { <http://www.wikidata.org/entity/Q37237228> ?p ?o ?g. }
- Q37237228 description "2016 թվականի օգոստոսի 30-ին հրատարակված գիտական հոդված" @default.
- Q37237228 description "article científic" @default.
- Q37237228 description "article scientifique" @default.
- Q37237228 description "articolo scientifico" @default.
- Q37237228 description "artigo científico" @default.
- Q37237228 description "artículu científicu espublizáu en 2016" @default.
- Q37237228 description "bilimsel makale" @default.
- Q37237228 description "scientific article published on 30 August 2016" @default.
- Q37237228 description "vedecký článok" @default.
- Q37237228 description "vetenskaplig artikel" @default.
- Q37237228 description "videnskabelig artikel" @default.
- Q37237228 description "vědecký článek" @default.
- Q37237228 description "wetenschappelijk artikel" @default.
- Q37237228 description "wissenschaftlicher Artikel" @default.
- Q37237228 description "наукова стаття, опублікована в серпні 2016" @default.
- Q37237228 description "научни чланак" @default.
- Q37237228 description "مقالة علمية نشرت في 30 أغسطس 2016" @default.
- Q37237228 name "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 name "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 name "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 type Item @default.
- Q37237228 label "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 label "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 label "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 prefLabel "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 prefLabel "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 prefLabel "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 P1433 Q37237228-C27209BF-9F27-413F-8841-3DECA8311174 @default.
- Q37237228 P1476 Q37237228-511C7620-700B-47CF-803E-88B8C3F09291 @default.
- Q37237228 P2093 Q37237228-0B966EFC-3708-4EF4-8170-AEA7C3241FB0 @default.
- Q37237228 P2093 Q37237228-2D928309-6467-49C7-9307-20F61B7D4152 @default.
- Q37237228 P2093 Q37237228-3542A9B2-0535-42D4-AB11-A80B3F2DB4BB @default.
- Q37237228 P2093 Q37237228-48F4E7D4-C46C-4103-8226-EB51A1F62DB0 @default.
- Q37237228 P2093 Q37237228-4A6EB742-EDA9-4ECE-9793-48C95A0EE40E @default.
- Q37237228 P2093 Q37237228-5EF18B91-D569-47B1-9236-22EDCE78E10D @default.
- Q37237228 P2093 Q37237228-6E466E9B-B029-406A-9CA3-4CF08500CF5F @default.
- Q37237228 P2093 Q37237228-7421A717-D847-4E3C-A05E-FB04DDD84E2E @default.
- Q37237228 P2093 Q37237228-7646DE6E-4EBA-4C58-B81B-877B5042FED9 @default.
- Q37237228 P2093 Q37237228-7B67C31C-876F-4BC9-BA56-333DBC61F183 @default.
- Q37237228 P2093 Q37237228-7F14AB7E-9C7A-40F8-A325-31D49CD8723D @default.
- Q37237228 P2093 Q37237228-9DFDB681-16F4-4DD8-A5E9-4340B1784F9D @default.
- Q37237228 P2093 Q37237228-AAB93F94-B411-4287-8038-3D68EB0A533D @default.
- Q37237228 P2093 Q37237228-AF0C1004-F667-4B56-8301-680677450AEC @default.
- Q37237228 P2093 Q37237228-BF96101F-20E1-45CD-B920-25943E0751F9 @default.
- Q37237228 P2093 Q37237228-CB07A873-EF12-41B8-93F8-39F2C6AAFD43 @default.
- Q37237228 P2093 Q37237228-E857AD90-1ADD-4E30-B6C5-B7B297A48FCC @default.
- Q37237228 P2093 Q37237228-F6D8A01A-FDC7-401C-B42A-FAF89D37E8A3 @default.
- Q37237228 P2093 Q37237228-F7F5BC1B-6EED-40B8-A31E-D9483D180FE2 @default.
- Q37237228 P2093 Q37237228-FBBD8DA9-AA8C-48D0-AAE2-C210C6F9DED8 @default.
- Q37237228 P275 Q37237228-3e2d55e2-a8f1-497e-9a7b-415b12cfee73 @default.
- Q37237228 P2860 Q37237228-09B9B7DA-6D15-40FC-B869-F255DE691B7A @default.
- Q37237228 P2860 Q37237228-0A35F11E-5717-4172-8B47-BC08D26C7BAB @default.
- Q37237228 P2860 Q37237228-0B24AFA2-563A-4712-9AB3-8109098BA859 @default.
- Q37237228 P2860 Q37237228-24F753BE-56AB-4B96-BE29-3A06F8570D26 @default.
- Q37237228 P2860 Q37237228-2B5CF2BA-558B-42EF-ABDE-825019D22CD6 @default.
- Q37237228 P2860 Q37237228-3556EC7A-A995-4391-B343-F8FBD564FC6F @default.
- Q37237228 P2860 Q37237228-3797F6EF-8B29-4674-9558-4CEE8CBA0448 @default.
- Q37237228 P2860 Q37237228-3F571052-B280-4374-A576-98DEC0D797FD @default.
- Q37237228 P2860 Q37237228-4417A6E9-0694-4332-A18C-B52AEBE638C3 @default.
- Q37237228 P2860 Q37237228-4A7D9D2C-76CE-4531-93C0-99BD5F220622 @default.
- Q37237228 P2860 Q37237228-5D1FCBE5-D285-469F-B2E0-4FEF3BB813A9 @default.
- Q37237228 P2860 Q37237228-5E447EA3-2263-4E06-8CAC-83DD8DA8C7B2 @default.
- Q37237228 P2860 Q37237228-6105BBEA-AD37-4C4A-9957-267BFF886837 @default.
- Q37237228 P2860 Q37237228-6815E2D3-5802-4135-9CA1-2FFA09159D9E @default.
- Q37237228 P2860 Q37237228-801A0393-A87D-4F8B-94D7-27E5BCC0D761 @default.
- Q37237228 P2860 Q37237228-803A7273-A37E-4F78-BF75-7B4B838367A1 @default.
- Q37237228 P2860 Q37237228-86D031A7-1CBE-443F-B3E3-6BD6E02B2D06 @default.
- Q37237228 P2860 Q37237228-9A38A7FF-486B-4651-814F-D11505F51E8F @default.
- Q37237228 P2860 Q37237228-9A721741-0C50-48F9-8302-77843C954A16 @default.
- Q37237228 P2860 Q37237228-A615F624-C95C-4D23-98D8-D00358FC8B57 @default.
- Q37237228 P2860 Q37237228-BAECAFF6-AD56-4E44-A0E8-9685ECA3BE2C @default.
- Q37237228 P2860 Q37237228-DF4F969B-E2A9-43D6-A1E5-BA4D7CE5EE69 @default.
- Q37237228 P2860 Q37237228-E5E4B466-5B53-413D-9854-2D99952D59F0 @default.
- Q37237228 P2860 Q37237228-EA499600-7D61-488A-9AD3-EF7F46486B76 @default.
- Q37237228 P2860 Q37237228-EB564439-8659-4F6E-90C6-40E3E60C7BA1 @default.
- Q37237228 P2860 Q37237228-F24773AB-4E2E-436B-AD42-7FBCD3E150CA @default.
- Q37237228 P2860 Q37237228-FFB54351-9268-4F88-9CFE-A170E0E39C4A @default.
- Q37237228 P2888 Q37237228-43B4F0C8-5D59-40BA-A95A-66B705A2A628 @default.
- Q37237228 P304 Q37237228-56ED0469-C2D0-4BA5-9A02-55674E6AA9B3 @default.
- Q37237228 P31 Q37237228-50266A55-5937-47A9-BEF5-DAA74CE27B90 @default.
- Q37237228 P356 Q37237228-9B99C570-C897-416E-A6C8-E7D0DE3721AB @default.
- Q37237228 P407 Q37237228-1C557F16-98A1-48EF-B3EE-92EE1A1F9FE3 @default.
- Q37237228 P478 Q37237228-943EAD1A-F99E-43D4-8BC5-2C7793A1E001 @default.
- Q37237228 P50 Q37237228-8496FE32-00EE-4FBC-9A55-724824678278 @default.
- Q37237228 P50 Q37237228-E86F107B-1AB9-4405-B43C-24135F9997E0 @default.
- Q37237228 P577 Q37237228-7271E7A7-C707-47DC-83E6-40174FEF06A9 @default.
- Q37237228 P6216 Q37237228-af9fdf84-c6f6-41a9-b031-66516e52805e @default.
- Q37237228 P698 Q37237228-2693B37F-E9B4-47BD-9FCA-4521E947EC92 @default.
- Q37237228 P819 Q37237228-8CF092F2-82F4-4A0B-8133-060551548B4C @default.
- Q37237228 P921 Q37237228-134FA6B6-AC1E-423F-BCA8-F3F336445285 @default.
- Q37237228 P921 Q37237228-4CF518F5-5A96-45AA-B21A-769BD91F0E05 @default.
- Q37237228 P921 Q37237228-DFAAFF39-A69E-4AF7-888C-8CD5AD448F97 @default.
- Q37237228 P932 Q37237228-419CAA9C-9D83-4941-AFA2-35126EF00912 @default.
- Q37237228 P356 NCOMMS12624 @default.
- Q37237228 P698 27571927 @default.
- Q37237228 P1433 Q573880 @default.
- Q37237228 P1476 "Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma" @default.
- Q37237228 P2093 "Daniel S Chen" @default.
- Q37237228 P2093 "Daniel Waterkamp" @default.
- Q37237228 P2093 "David F McDermott" @default.